Yea Christopher bought KALV
May 17, 2026 · Form 4 insider transaction
Yea Christopher bought 1,774 shares of KalVista Pharmaceuticals Inc, a transaction worth N/A. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
1,774
Price
N/A
Total value
N/A
InsiderYea Christopher
RoleOfficer
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateMay 17, 2026
Filing dateMay 19, 2026
Shares owned after228,475
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Each restricted stock unit ("RSU") represents a contingent right to receive 1 share of the Issuer's Common Stock upon settlement for no consideration.